Another investigation revealed that CYP4Z2P and its pseudogene, CYP4Z1-3′UTR, enhanced tumor neovascularization in breast cancer, presumably by activating the ERK1/2 and PI3K/Akt cascades [71]. The gene discussed is MAPK3; the disease is breast carcinoma.